Cimeio Therapeutics announced that it has entered a research collaboration with Kyowa Kirin Co., Ltd. to develop a novel therapy for diseases with high...
Dragonfly Therapeutics, Inc., a clinical stage biotechnology company developing novel immunotherapies, announced the April 13th publication of preclinical data in Cell Press's Med supporting DF6002...